Breeze Meds vs RNK Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Breeze Meds
Best for compounded GLP-1 access with named prescribers and 4-pharmacy networkStarting at $199/mo
RNK Health
Best for compounded GLP-1 buyers also interested in NAD+, peptide, or longevity add-ons in the same provider relationshipStarting at $197/mo
Side-by-Side Comparison
| Feature | Breeze Meds | RNK Health |
|---|---|---|
| Overall Score | 7.3/10 | 7.3/10 |
| Starting Price | $199/mo | ✓$197/mo |
| Editorial Rating | 3.7 ★ /5 | 3.7 ★ /5 |
| Features | ✓6 features | 5 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Breeze Meds
Pros
- ✓Available in all 50 US states
- ✓LegitScript certified seal displayed in footer
- ✓Publicly named medical team with NPI numbers: Dr. Ana Lisa Carr MD (NPI 1689841744) and Dr. Kelly Tenbrink MD (NPI 1346482684)
- ✓Four named 503A pharmacy partners: Belmar Pharma Solutions, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx
- ✓Both injectable and oral formats available for semaglutide and tirzepatide
- ✓No FDA warning letters or litigation on record as of 2026-04-09
Cons
- ✗Runs on the same Lion MD clinician network and the same 4 compounding pharmacies as Care Bare Rx and Synergy Rx — if you're comparing the three brands, be aware you're comparing three storefronts on top of one underlying operation, not three independent providers
- ✗Compounded medications are not FDA-approved
- ✗Compounded vs. brand-name drug sourcing is ambiguously disclosed on the product pages
- ✗Terms of Service page returns a 404 (Privacy Policy is present) — a procedural transparency gap
- ✗Insurance acceptance is not clearly disclosed beyond FSA/HSA eligibility
RNK Health
Pros
- ✓Both injectable and oral compounded semaglutide formats — wider format optionality than most stub entries in the cluster
- ✓GLP-1 + longevity stack (NAD+, sermorelin, enclomiphene, DNA testing) lets one provider serve readers also interested in performance/longevity adjacencies
- ✓Pricing is publicly displayed — $297/mo tirzepatide, $197/mo injectable semaglutide, $198/mo oral semaglutide
Cons
- ✗States served not enumerated on the public landing page — needs direct confirmation before any state-page placement
- ✗Pharmacy partner not publicly named beyond a Springville, UT fulfillment reference
- ✗Compounded only on the GLP-1 side — no FDA-approved Wegovy/Zepbound brand-name option
Our Verdict
Both Breeze Meds and RNK Health score equally well overall — the right choice depends on your priorities. Choose Breeze Meds if you want compounded GLP-1 access with named prescribers and 4-pharmacy network, or RNK Health if compounded GLP-1 buyers also interested in NAD+, peptide, or longevity add-ons in the same provider relationship matters most to you.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.